Schinzel Giedion Syndrome is a rare genetic disorder characterized by a variety of physical and mental abnormalities. It is caused by a mutation in the SMARCE1 gene. Symptoms may include delayed growth and development, intellectual disability, distinctive facial features, skeletal abnormalities, and heart defects. Treatment is based on the individual's symptoms and may include physical therapy, speech therapy, and medications.

The symptoms of Schinzel Giedion Syndrome vary from person to person, but some of the most common symptoms include:

-Delayed growth and development
-Intellectual disability
-Seizures
-Feeding difficulties
-Cleft lip and/or palate
-Widely spaced eyes
-Low-set ears
-Short stature
-Abnormal facial features
-Heart defects
-Kidney abnormalities
-Hearing loss
-Gastrointestinal problems
-Skeletal abnormalities
-Skin abnormalities

Schinzel Giedion Syndrome is a rare genetic disorder caused by a mutation in the SMARCE1 gene. The exact cause of the mutation is unknown, but it is believed to be inherited in an autosomal recessive pattern.

Unfortunately, there is no known cure for Schinzel Giedion Syndrome. Treatment is focused on managing the symptoms and complications associated with the condition. This may include physical therapy, occupational therapy, speech therapy, and other supportive therapies. In some cases, medications may be prescribed to help manage seizures, breathing difficulties, and other medical issues. Surgery may be recommended to correct certain physical abnormalities.

The exact cause of Schinzel Giedion Syndrome is unknown, but it is believed to be caused by a genetic mutation. Risk factors for the condition include a family history of the disorder, being of European descent, and being a male.

Unfortunately, there is no cure for Schinzel Giedion Syndrome. However, there are medications and treatments available to help manage the symptoms. These include physical therapy, occupational therapy, speech therapy, and medications to help with seizures, breathing, and other medical issues.